Optimal EPO dosing in hemodialysis patients using a non-linear model predictive control approach

Loading...
Thumbnail Image
Date
2019
Authors
Fuertinger, Doris H.
Kappel, Franz
Kotanko, Peter
Editors
Contact
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
DOI (citable link)
ArXiv-ID
International patent number
Link to the license
EU project number
Project
Open Access publication
Restricted until
Title in another language
Research Projects
Organizational Units
Journal Issue
Publication type
Journal article
Publication status
Published
Published in
Journal of Mathematical Biology ; 79 (2019), 6-7. - pp. 2281-2313. - Springer. - ISSN 0303-6812. - eISSN 1432-1416
Abstract
Anemia management with erythropoiesis stimulating agents is a challenging task in hemodialysis patients since their response to treatment varies highly. In general, it is difficult to achieve and maintain the predefined hemoglobin (Hgb) target levels in clinical practice. The aim of this study is to develop a fully personalizable controller scheme to stabilize Hgb levels within a narrow target window while keeping drug doses low to mitigate side effects. First in-silico results of this framework are presented in this paper. Based on a model of erythropoiesis we formulate a non-linear model predictive control (NMPC) algorithm for the individualized optimization of epoetin alfa (EPO) doses. Previous to this work, model parameters were estimated for individual patients using clinical data. The optimal control problem is formulated for a continuous drug administration. This is currently a hypothetical form of drug administration for EPO as it would require a programmable EPO pump similar to insulin pumps used to treat patients with diabetes mellitus. In each step of the NMPC method the open-loop problem is solved with a projected quasi-Newton method. The controller is successfully tested in-silico on several patient parameter sets. An appropriate control is feasible in the tested patients under the assumption that the controlled quantity is measured regularly and that continuous EPO administration is adjusted on a daily, weekly or monthly basis. Further, the controller satisfactorily handles the following challenging problems in simulations: bleedings, missed administrations and dosing errors.
Summary in another language
Subject (DDC)
510 Mathematics
Keywords
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690ROGG, Sabrina, Doris H. FUERTINGER, Stefan VOLKWEIN, Franz KAPPEL, Peter KOTANKO, 2019. Optimal EPO dosing in hemodialysis patients using a non-linear model predictive control approach. In: Journal of Mathematical Biology. Springer. 79(6-7), pp. 2281-2313. ISSN 0303-6812. eISSN 1432-1416. Available under: doi: 10.1007/s00285-019-01429-1
BibTex
@article{Rogg2019Optim-41065.2,
  year={2019},
  doi={10.1007/s00285-019-01429-1},
  title={Optimal EPO dosing in hemodialysis patients using a non-linear model predictive control approach},
  number={6-7},
  volume={79},
  issn={0303-6812},
  journal={Journal of Mathematical Biology},
  pages={2281--2313},
  author={Rogg, Sabrina and Fuertinger, Doris H. and Volkwein, Stefan and Kappel, Franz and Kotanko, Peter}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/41065.2">
    <dc:contributor>Rogg, Sabrina</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/41065.2/1/Rogg_2-1ghv42fqlclc0.pdf"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/41065.2/1/Rogg_2-1ghv42fqlclc0.pdf"/>
    <dc:creator>Fuertinger, Doris H.</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39"/>
    <dc:contributor>Volkwein, Stefan</dc:contributor>
    <dc:contributor>Kappel, Franz</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-24T13:11:53Z</dcterms:available>
    <dcterms:title>Optimal EPO dosing in hemodialysis patients using a non-linear model predictive control approach</dcterms:title>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:issued>2019</dcterms:issued>
    <dc:creator>Volkwein, Stefan</dc:creator>
    <dc:contributor>Fuertinger, Doris H.</dc:contributor>
    <dc:contributor>Kotanko, Peter</dc:contributor>
    <dc:creator>Rogg, Sabrina</dc:creator>
    <dc:language>eng</dc:language>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-06-24T13:11:53Z</dc:date>
    <dc:creator>Kotanko, Peter</dc:creator>
    <dcterms:abstract xml:lang="eng">Anemia management with erythropoiesis stimulating agents is a challenging task in hemodialysis patients since their response to treatment varies highly. In general, it is difficult to achieve and maintain the predefined hemoglobin (Hgb) target levels in clinical practice. The aim of this study is to develop a fully personalizable controller scheme to stabilize Hgb levels within a narrow target window while keeping drug doses low to mitigate side effects. First in-silico results of this framework are presented in this paper. Based on a model of erythropoiesis we formulate a non-linear model predictive control (NMPC) algorithm for the individualized optimization of epoetin alfa (EPO) doses. Previous to this work, model parameters were estimated for individual patients using clinical data. The optimal control problem is formulated for a continuous drug administration. This is currently a hypothetical form of drug administration for EPO as it would require a programmable EPO pump similar to insulin pumps used to treat patients with diabetes mellitus. In each step of the NMPC method the open-loop problem is solved with a projected quasi-Newton method. The controller is successfully tested in-silico on several patient parameter sets. An appropriate control is feasible in the tested patients under the assumption that the controlled quantity is measured regularly and that continuous EPO administration is adjusted on a daily, weekly or monthly basis. Further, the controller satisfactorily handles the following challenging problems in simulations: bleedings, missed administrations and dosing errors.</dcterms:abstract>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/41065.2"/>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:creator>Kappel, Franz</dc:creator>
  </rdf:Description>
</rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Contact
URL of original publication
Test date of URL
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes
Refereed
Yes

Version History

Now showing 1 - 2 of 2
VersionDateSummary
2*
2020-06-24 13:07:40
2018-01-15 15:32:21
* Selected version